Literature DB >> 12518239

Angiogenesis in pterygium: morphometric and immunohistochemical study.

Arie L Marcovich1, Yair Morad, Judith Sandbank, Monica Huszar, Mordechai Rosner, Ayala Pollack, Mehrdad Herbert, Yaron Bar-Dayan.   

Abstract

OBJECTIVE: To evaluate the role of angiogenesis in the pathogenesis of pterygium by comparing the expression of von-Willebrand factor (vWF) and vascular endothelial growth factor (VEGF) in pterygium, and in normal superior bulbar conjunctiva.
METHODS: 23 human samples from pterygium and the superior bulbar conjunctiva were stained using rabbit anti-vWF and anti-VEGF antibodies. The density of vWF and VEGF positive vessels, VEGF staining intensity and the number of VEGF positive stromal, epithelial and vascular endothelial cells were evaluated.
RESULTS: Pterygium specimens had higher average vWF and VEGF positive microvascular counts per high power field (P = 0.0012), higher average VEGF staining intensity scores in epithelial, stromal and endothelial cells (p < 0.0001) and higher VEGF positive cell counts (P < 0.0001) than normal conjuctiva.
CONCLUSIONS: Over-expression of VEGF in pterygium tissue, together with the abundance of vWF-stained new vessels, may support previous suggestions that angiogenesis may play a role in the formation of pterygium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12518239     DOI: 10.1076/ceyr.25.1.17.9959

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  32 in total

1.  Pterygium.

Authors:  A S Solomon
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

2.  EphB4 expression in pterygium is associated with microvessel density.

Authors:  Chunyan Xue; Yueqin Chen; Zhenping Huang; Yirui Ge; Haiyan Wang; Jiandong Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision.

Authors:  Sameh Mohamed Elgouhary; Hesham Fouad Elmazar; Mariana Ibrahim Naguib; Noha Rabie Bayomy
Journal:  Int Ophthalmol       Date:  2020-06-06       Impact factor: 2.031

4.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

5.  Correlation of vascular endothelial growth factor and CD105-microvascular density in primary pterygium.

Authors:  Jie Zhang; Mingchang Zhang; Xiaoqing Li; Tian Zheng; Ge Mu; Wei Liu; Huatao Xie; Xin Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

6.  Analysis of pathohistological characteristics of pterygium.

Authors:  Boban Džunić; Predrag Jovanović; Dragan Veselinović; Aleksandar Petrović; Ivan Stefanović; Igor Kovačević
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

7.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

8.  Immunohistochemical study of vascular endothelial growth factor (VEGF), tumor suppressor protein (p53) and intercellular adhesion molecule (ICAM-1) in the conjunctiva of diabetic patients.

Authors:  Lidia Kria; Taoufik Khalfaoui; Ghada Mkannez; Omar Beltaief; Raja Anane; Khalil Errais; Lilia Tounsi; Raja Zhioua; Sarra Ben Jilani; Amel Meddeb Ouertani
Journal:  J Mol Histol       Date:  2006-02-16       Impact factor: 2.611

9.  Correlation between NGF/TrkA and microvascular density in human pterygium.

Authors:  Domenico Ribatti; Beatrice Nico; Maria Teresa Perra; Cristina Maxia; Franca Piras; Daniela Murtas; Enrico Crivellato; Paola Sirigu
Journal:  Int J Exp Pathol       Date:  2009-09-15       Impact factor: 1.925

10.  Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study.

Authors:  Tarek A Mohamed; Wael Soliman; Ahmed M Fathalla; Abeer El Refaie
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.